Publication | Open Access

Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™

VaccinationAllergyVaccine DevelopmentImmunodeficienciesAntigen-specific ImmunityImmunologyTumor ImmunityImmunodominanceTherapeutic VaccineHumoral ImmunityImmunotherapeuticsT Cell ImmunityVaccine DesignImmune SystemMedicineVaccine ResearchNy-eso-1 Protein